- Home
- OVID vs CING Comparison
OVID vs CING Comparison
Compare OVID & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- CING
- Stock Information
- Founded
- OVID 2014
- CING 2012
- Country
- OVID United States
- CING United States
- Employees
- OVID N/A
- CING N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- CING Health Care
- Exchange
- OVID Nasdaq
- CING Nasdaq
- Market Cap
- OVID 20.6M
- CING 17.3M
- IPO Year
- OVID 2017
- CING 2021
- Fundamental
- Price
- OVID $0.62
- CING $5.50
- Analyst Decision
- OVID Strong Buy
- CING Strong Buy
- Analyst Count
- OVID 4
- CING 4
- Target Price
- OVID $3.13
- CING $30.67
- AVG Volume (30 Days)
- OVID 2.9M
- CING 104.7K
- Earning Date
- OVID 08-12-2025
- CING 08-12-2025
- Dividend Yield
- OVID N/A
- CING N/A
- EPS Growth
- OVID N/A
- CING N/A
- EPS
- OVID N/A
- CING N/A
- Revenue
- OVID $548,000.00
- CING N/A
- Revenue This Year
- OVID N/A
- CING N/A
- Revenue Next Year
- OVID $5.32
- CING N/A
- P/E Ratio
- OVID N/A
- CING N/A
- Revenue Growth
- OVID 15.61
- CING N/A
- 52 Week Low
- OVID $0.24
- CING $1.80
- 52 Week High
- OVID $1.47
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- OVID 68.33
- CING 66.64
- Support Level
- OVID $0.60
- CING $4.25
- Resistance Level
- OVID $0.73
- CING $6.01
- Average True Range (ATR)
- OVID 0.07
- CING 0.34
- MACD
- OVID 0.03
- CING 0.09
- Stochastic Oscillator
- OVID 69.12
- CING 71.02
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.